Teva Sprints Ahead of the API Field

With active pharmaceutical ingredient sales of $1.46 million in 2007 and a portfolio of more than 250 compounds, Teva Pharmaceutical Industries is by a long stretch the dominant supplier in the global API market.
in-Pharma Technolgist